| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |